Patent details

300702 Product Name: Vedolizumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300702
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1278543
Status:
SPC in force
Application number:
300702
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/14/923
Marketing Authorization Type:
EEA
Marketing Authorization Date:
27/05/2014
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
11/11/2014
First Marketing Authorization date:
27/05/2014
Grant date:
28/01/2016
Activation date:
13/04/2021
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/11/2014
SPC/SPC Extension Expiration Date:
12/04/2026
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
23/03/2022
 
 

 

Name:
Genentech, Inc.
Address:
1 DNA Way, SOUTH SAN FRANCISCO, CA 94080-4990, United States of America (US)

From:
23/03/2022
 
 

 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, 541-0045, Osaka , Japan (JP)

Historical Applicant/holder

From:
23/03/2022
To:
23/03/2022

 

Name:
MILLENNIUM PHARMACEUTICALS, INC.
Address:
40 Landsdowne Street, 02139, Cambridge, MA, United States of America (US)

From:
11/11/2014
To:
23/03/2022

 

Name:
MILLENNIUM PHARMACEUTICALS, INC.
Address:
75 Sidney Street, CAMBRIDGE, MASSACHUSETTS 02139, United States of America (US)

From:
11/11/2014
To:
23/03/2022

 

Name:
Genentech, Inc.
Address:
1 DNA Way, SOUTH SAN FRANCISCO, CA 94080-4990, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
11/11/2014
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
17/22
Publication date:
29/04/2022
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
SPC
Journal edition number:
15/21
Publication date:
14/04/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
05/16
Publication date:
03/02/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
2014/48
Publication date:
26/11/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202200726A
Date Registered:
23/03/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202200726B
Date Registered:
23/03/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Genentech, Inc.
Address:
1 DNA Way, SOUTH SAN FRANCISCO, CA 94080-4990, United States of America (US)

2

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, 541-0045, Osaka , Japan (JP)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
09/04/2025
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
NLO
Filing date Document type Document Description Number of pages File Type
28/01/2016 Outgoing Correspondence Outgoing Letter 1 PDF /2/0/7/0/0/0400300702/docs/300702_3_outgoingcorrespondence20201019032530096.pdf
28/01/2016 SPC Documents Certificate SPC 1 PDF /2/0/7/0/0/0400300702/docs/300702_4_supplprotectioncertificate20201019032355989.pdf
04/05/2015 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /2/0/7/0/0/0400300702/docs/300702_1_incomingcorrespondencepaper20150504.pdf
26/03/2015 Outgoing Correspondence Outgoing Letter 1 PDF /2/0/7/0/0/0400300702/docs/300702_2_outgoingcorrespondence20150326.pdf
04/03/2015 Incoming Correspondence Electronic Accompanying letter incoming document 1 PDF /2/0/7/0/0/0400300702/docs/300702_8_incomingcorrespondenceelectronic20201019030127909.pdf
04/12/2014 Outgoing Correspondence Outgoing Letter 2 PDF /2/0/7/0/0/0400300702/docs/300702_0_outgoingcorrespondence20141204.pdf
17/11/2014 Outgoing Correspondence Outgoing Letter 1 PDF /2/0/7/0/0/0400300702/docs/300702_5_outgoingcorrespondence20141117.pdf
11/11/2014 SPC Documents Annex SPC 3 PDF /2/0/7/0/0/0400300702/docs/300702_6_supplprotectioncertificate20201019025831426.pdf
11/11/2014 SPC Documents Summary of the characteristics of the product 21 PDF /2/0/7/0/0/0400300702/docs/300702_7_supplprotectioncertificate20201019025646524.pdf
11/11/2014 SPC Documents Marketing Authorization SPC 4 PDF /2/0/7/0/0/0400300702/docs/300702_9_supplprotectioncertificate20201019021134447.pdf
11/11/2014 Application Form First filed application form 2 PDF /2/0/7/0/0/0400300702/docs/300702_10_applicationform20141111.pdf